Knoll Capital Management, LLC Diversified Active

CIK: 0001325083 · Show all filings

Period: Q2 2017 (← Previous) (Next →)

Filing Date: Aug 14, 2017

Total Value ($000): $75,436 (100.0% shares, 0.0% debt)

Holdings (15)

— Corbus Pharmaceuticals HLDGS 31.2%

Value ($000) $23,555 Shares 3,738,925 Est. Cost $4.33 Unrealized —

— Biohaven Pharmactl Hldg Co L 26.8%

Value ($000) $20,181 Shares 807,224 Est. Cost $25.00 Unrealized —

— Abeona Therapeutics Inc 20.0%

Value ($000) $15,103 Shares 2,359,767 Est. Cost $4.97 Unrealized —

AVXL Anavex Life Sciences Corp 5.1%

Value ($000) $3,853 Shares 724,205 Est. Cost $3.56 Unrealized +62.3%

— Vascular Biogenics LTD 5.1%

Value ($000) $3,830 Shares 860,605 Est. Cost $4.61 Unrealized —

VNRX Volition RX LTD 2.1%

Value ($000) $1,620 Shares 461,538 Est. Cost $3.75 Unrealized -3.9%

— Keryx Biopharmaceuticals Inc. 1.9%

Value ($000) $1,446 Shares 200,000 Est. Cost $10.21 Unrealized —

— Alcobra Ltd 1.8%

Value ($000) $1,350 Shares 1,205,498 Est. Cost $6.71 Unrealized —

— Ampio Pharmaceuticals Inc. 1.8%

Value ($000) $1,350 Shares 2,595,484 Est. Cost $6.03 Unrealized —

— Summit Therapeutics PLC 1.5%

Value ($000) $1,099 Shares 100,000 Est. Cost $13.27 Unrealized —

ALDX Aldeyra Therapeutics Inc 0.8%

Value ($000) $583 Shares 124,096 Est. Cost $10.20 Unrealized -54.9%

— Caladrius Biosciences Inc 0.7%

Value ($000) $549 Shares 117,957 Est. Cost $3.99 Unrealized —

— Evoke Pharma Inc 0.6%

Value ($000) $448 Shares 175,000 Est. Cost $3.10 Unrealized —

— Advaxis Inc. 0.5%

Value ($000) $368 Shares 112,500 Est. Cost $3.96 Unrealized —

— Lipocine Inc New 0.1%

Value ($000) $101 Shares 25,000 Est. Cost $4.04 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	Corbus Pharmaceuticals HLDGS	3,738,925	$23,555	31.2%	$4.33	—	COM	21833P103
—	Biohaven Pharmactl Hldg Co L	807,224	$20,181	26.8%	$25.00	—	COM	G11196105
—	Abeona Therapeutics Inc	2,359,767	$15,103	20.0%	$4.97	—	COM	00289Y107
AVXL	Anavex Life Sciences Corp	724,205	$3,853	5.1%	$3.56	+62.3%	COM NEW	032797300
—	Vascular Biogenics LTD	860,605	$3,830	5.1%	$4.61	—	COM	M96883109
VNRX	Volition RX LTD	461,538	$1,620	2.1%	$3.75	-3.9%	COM	928661107
—	Keryx Biopharmaceuticals Inc.	200,000	$1,446	1.9%	$10.21	—	COM	492515101
—	Alcobra Ltd	1,205,498	$1,350	1.8%	$6.71	—	SHS	M2239P109
—	Ampio Pharmaceuticals Inc.	2,595,484	$1,350	1.8%	$6.03	—	COM	03209T109
—	Summit Therapeutics PLC	100,000	$1,099	1.5%	$13.27	—	SPONS ADS	86627R102
ALDX	Aldeyra Therapeutics Inc	124,096	$583	0.8%	$10.20	-54.9%	COM	01438T106
—	Caladrius Biosciences Inc	117,957	$549	0.7%	$3.99	—	COM NEW	128058203
—	Evoke Pharma Inc	175,000	$448	0.6%	$3.10	—	COM	30049G104
—	Advaxis Inc.	112,500	$368	0.5%	$3.96	—	W EXP 07/15/201	007624117
—	Lipocine Inc New	25,000	$101	0.1%	$4.04	—	COM	53630X104